Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real‐world use of sodium–glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
Davide Stolfo, Lars H. Lund, Lina Benson, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 9, pp. 1648-1658
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 35
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
Gianluigi Savarese, Felix Lindberg, Antonio Cannatà, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1278-1297
Open Access | Times Cited: 18
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease
Finn Gustafsson, Nir Uriel, Ivan Netuka, et al.
JAMA Cardiology (2025)
Closed Access | Times Cited: 2
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC
Giuseppe Rosano, Davide Stolfo, Lisa Anderson, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 8, pp. 1669-1686
Open Access | Times Cited: 13
Physician perceptions, attitudes, and strategies towards implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
Gianluigi Savarese, Felix Lindberg, Ruxandra Christodorescu, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1408-1418
Open Access | Times Cited: 12
European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC
Amr Abdin, Chris Wilkinson, Suleman Aktaa, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 9
Temporal trends in guideline-recommended medical therapy after an acute heart failure decompensation event: an observational analysis from Generator Heart Failure DataMart
Renzo Laborante, Agni Delvinioti, Aura Tudor, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e088998-e088998
Open Access | Times Cited: 1
Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
Lars H. Lund, María G. Crespo‐Leiro, Cécile Laroche, et al.
European Journal of Heart Failure (2024)
Closed Access | Times Cited: 8
Características clínicas y tratamiento farmacológico de los pacientes con insuficiencia cardíaca en una cohorte de atención primaria
Maria Giner-Sorian, Ramon Monfà, Roser Vives, et al.
Atención Primaria (2025) Vol. 57, Iss. 7, pp. 103205-103205
Closed Access
Physicians’ knowledge of therapy that affecting the prognosis of patients with chronic heart failure
Н. Б. Перепеч, I. E. Mikhailova, А. В. Трегубов
Rational Pharmacotherapy in Cardiology (2025) Vol. 21, Iss. 1, pp. 14-21
Open Access
A multicentre registry of hospitalized patients with acute and chronic heart failure: Study design of the H2‐registry
Johannes Leiner, Sebastian König, Anne Nitsche, et al.
ESC Heart Failure (2025)
Open Access
Real‐world use of guideline‐directed therapy for heart failure: Insights from the Danish Heart Failure Registry
Inge Schjødt, Jan Brink Valentin, Søren Paaske Johnsen, et al.
ESC Heart Failure (2025)
Open Access
Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
Health Care Expenditure among US Adults with Heart Failure with and without Diabetes
Chintal H. Shah, Gregg C. Fonarow, Justin B. Echouffo‐Tcheugui
The American Journal of Cardiology (2024) Vol. 228, pp. 10-15
Closed Access | Times Cited: 3
Real‐world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED–HEART study
Umut Kocabaş, Işıl Ergin, Veysel Yavuz, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 3
Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?
Stephen J. Greene, Muhammad Shahzeb Khan, Javed Butler
European Journal of Heart Failure (2024) Vol. 26, Iss. 2, pp. 338-341
Closed Access | Times Cited: 2
Sex Differences in Cardiac and Clinical Phenotypes and Their Relation to Outcomes in Patients with Heart Failure
Akane Kawai, Yuji Nagatomo, Midori Yukino-Iwashita, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 201-201
Open Access | Times Cited: 2
Trends in heart failure mortality in Sweden between 1997 and 2022
Felix Lindberg, Lina Benson, Ulf Dahlström, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 2
Guideline-Recommended Therapy Following Hospitalization for Heart Failure
Tauben Averbuch, Stephen J. Greene, Harriette G.C. Van Spall
JACC Heart Failure (2023) Vol. 11, Iss. 10, pp. 1333-1336
Open Access | Times Cited: 4
Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery
Lars H. Lund, María G. Crespo‐Leiro, Cécile Laroche, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 12, pp. 2316-2330
Open Access | Times Cited: 4
What we claim to do and what we really do – a discrepancy in heart failure treatment
Birgit Aßmus, Samuel Sossalla
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1419-1422
Closed Access | Times Cited: 1
Status and timing of angiotensin receptor–neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
Davide Stolfo, Lina Benson, Felix Lindberg, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2243-2257
Open Access | Times Cited: 1
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
Viveca Ritsinger, Kamila Avander, Bo Lagerqvist, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC
Ruxandra Christodorescu, Oliviana Geavlete, Marc Ferrini, et al.
European Journal of Heart Failure (2024)
Closed Access | Times Cited: 1
High long-term mortality in ischaemic heart disease accentuated among ethnic minorities in Eastern Europe: findings from a prospective all-comers percutaneous coronary intervention registry in Romania
Paul‐Adrian Călburean, Paul Grebenișan, Ioana-Andreea Nistor, et al.
Journal of Epidemiology & Community Health (2024), pp. jech-222845
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top